REG - Adv Medical Solutns. - Notice of AGM

Advanced Medical SolutionsAnnouncement

Yesterday 14:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260515:nRSO5821Ea&default-theme=true

RNS Number : 5821E  Advanced Medical Solutions Grp PLC  15 May 2026

 

            15 May 2026

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

 

Annual Report and Notice of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a world-leading
specialist in tissue-healing technologies, is pleased to announce that its
Annual Report and Accounts for the year ended 31 December 2025 and Notice of
Annual General Meeting ("AGM") have today been sent to shareholders.

 

The Annual Report and Accounts is available on the Investor Relations section
of the Company's website https://admedsol.com/Investor-Relations.

 

The AGM will be held at 11:00 a.m. at the offices of Investec Bank plc, 30
Gresham Street, London, EC2V 7QN on 17 June 2026.

 

A copy of the proxy form for the AGM and Notice of AGM are available on the
Company's website
https://admedsol.com/investor-relations/shareholder-information/agm
(https://admedsol.com/investor-relations/shareholder-information/agm) .

 

- End -

 

For further information, please visit www.admedsol.com
(http://www.admedsol.com) or contact:

 

 Advanced Medical Solutions Group plc        Tel: +44 (0) 1606 545508
 Chris Meredith, Chief Executive Officer

 Eddie Johnson, Chief Financial Officer

 Michael King, Investor Relations

 Optimum Strategic Communications            Tel: +44 (0) 20 4566 8543
 Mary Clark / Nick Bastin / Isabelle Abdou   AMS@optimumcomms.com

 Investec Bank PLC (NOMAD & Broker)          Tel: +44 (0) 20 7597 5970
 Gary Clarence / David Anderson

 Berenberg (Joint Broker)                    Tel: +44 (0) 20 3207 7800
 Toby Flaux / Detlir Elezi

 

About Advanced Medical Solutions Group plc - see www.admedsol.com
(http://www.admedsol.com)

AMS is an innovative tissue healing medical device company delivering
high-performing solutions that match or surpass market leaders, clinically,
technically, and commercially. From adhesives and sealants, to biosurgical
devices and sutures, AMS's products offer superior usability, quality and
design. AMS's strength lies in combining advanced material science with
applicator device design and development, in collaboration with surgeons and
Key Opinion Leaders, creating differentiated devices that improve patient
outcomes without compromising quality or affordability.

AMS's scalable, resilient business model is built on disciplined execution,
portfolio focus, and capital efficiency. Its diversified product and
geographic mix mitigates volatility, ensuring consistent performance even when
individual segments fluctuate. Following its acquisition of Peters Surgical,
AMS is unlocking operational and commercial synergies, accelerating its US and
international expansion, and increasing the percentage of sales made through
its direct sales teams. With surgical products driving the lion's share of
group revenues and a clear top-line trajectory, AMS is positioned for scalable
growth, and long-term value creation.

-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOASFAFDIEMSESI



            Copyright 2019 Regulatory News Service, all rights reserved